Seeking Alpha
03 Aug 2026, 17:49 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Johnson & Johnson is pursuing FDA authorization for the OTTAVA robotic surgical system. — Approval would allow JNJ to enter the high-growth robotic surgery market and directly compete with Intuitive Surgical.
+0.60The company is preparing for the commercial market introduction of the OTTAVA system following anticipated regulatory clearance. — Successful commercialization represents a new long-term revenue stream and expansion of the MedTech portfolio.
+0.40Which stocks this story touches
The company is discussing the FDA authorization and market launch of its new OTTAVA robotic surgical system, representing a significant growth opportunity.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
7h ago
